Docket Room.
HB 1133·MD·house

Public Health - Drug Manufacturer-Funded Disease Awareness Campaigns - Registration and Required Disclosure

FailedFiled Feb 11, 2026
Sponsor: Taveras
Latest Action

Hearing (House)

Mar 12, 2026

Email me when HB 1133 moves

Committee action, floor votes, amendments and hearings. Free, no card, no password.

Already have an account? Track HB 1133. By continuing you agree to the Terms and Privacy Policy.

Summary

The bill forces drug manufacturers and any patient advocacy organization that receives their funding to file a registration with the Maryland Department of Health before launching a disease‑awareness effort. Campaign materials must clearly state the specific drug or device being marketed for the condition featured. This aims to increase transparency for the public about commercial influences behind health information.

AI-generated summary — may be incomplete or inaccurate. Verify against the official bill text.

Ask about HB 1133

3 free questions a day, no account

Hearings

History

  1. Hearing 3/12 at 1:00 p.m.
  2. First Reading Health

Sponsors

  • Taveras · sponsor
  • Acevero
  • Hill
  • Kaufman
  • Lehman
  • Odom
  • Ruff
  • Terrasa

Bill text

Read the official text ↗

Opens the legislature’s own copy.

Similar bills in other states

Loading the map of where bills like this one were filed.

Share

Writing about this bill? Add a live status widget to your site or newsletter. It updates as the bill moves.

Track this bill

Get an email when HB 1133 moves: committee action, floor votes, amendments and hearings. Free, no card.

Track HB 1133 free

Or ask your AI assistant about HB 1133 directly:

Add to Claude, ChatGPT or Cursor
Docket Room · Nonpartisan legislative tracking
Docket Room IntelligencePro

Ask about your legislation

I can analyze your tracked bills, upcoming hearings, and recent changes.

AI-generated · Nonpartisan · Not legal advice